Progression Criteria for Cancer Antigen 15.3 and Carcinoembryonic Antigen in Metastatic Breast Cancer Compared by Computer Simulation of Marker Data
Open Access
- 1 July 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 46 (7) , 939-949
Abstract
Background: We investigated the utility of computer simulation models for performance comparisons of different tumor marker assessment criteria to define progression or nonprogression of metastatic breast cancer. Methods: Clinically relevant values for progressive cancer antigen 15.3 and carcinoembryonic antigen concentrations were combined with representative values for background variations in a computer simulation model. Fifteen criteria for assessment of longitudinal tumor marker data were obtained from the literature and computerized. Altogether, 7200 different patients, each based on 50 measurements, were simulated. With a sampling interval of 4 weeks, the monitoring period for each event was ∼3.8 years. Results: Modulation of the background variation, the starting concentrations, and the cutoffs enabled identification of criteria that were robust against false-positive signals of progression. Conclusions: The computer simulation model is a fast, effective, and inexpensive approach for comparing the diagnostic potential of assessment criteria during clinically relevant conditions of steady-state and progressive disease. The model systems can be used to generate tumor marker assessment criteria for a variety of malignancies and to compare and optimize their diagnostic performance.Keywords
This publication has 14 references indexed in Scilit:
- Analytical Quality Specifications for Serum Lactate Dehydrogenase Isoenzyme 1 Based on Clinical GoalsClinical Chemistry and Laboratory Medicine (CCLM), 1999
- Computer-aided test selection and result validation-opportunities and pitfalls.Clinica Chimica Acta, 1998
- Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plotsClinical Chemistry, 1997
- Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease.Journal of Clinical Oncology, 1997
- Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-upClinical Chemistry, 1996
- Clinical utility and validation of emerging biochemical markers for mammary adenocarcinomaClinical Chemistry, 1993
- Interpretation of results for tumor markers on the basis of analytical imprecision and biological variationClinical Chemistry, 1993
- CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancerClinica Chimica Acta, 1991
- CA-15.3, TPA and MCA as markers for breast cancerEuropean Journal of Cancer, 1990
- Working Group on Tumor Marker Criteria (WGTMC)Tumor Biology, 1990